Lord, Abbett & Co. LLC Vera Therapeutics, Inc. Transaction History
Lord, Abbett & Co. LLC
- $31.4 Billion
- Q3 2024
A detailed history of Lord, Abbett & Co. LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 426,014 shares of VERA stock, worth $14.2 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
426,014
Previous 426,014
-0.0%
Holding current value
$14.2 Million
Previous $18.8 Million
-0.0%
% of portfolio
0.06%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding VERA
# of Institutions
185Shares Held
55.2MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$144 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$131 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$111 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$98.8 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$93.2 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $902M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...